HotSpot Therapeutics Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 47
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $100M
Latest Deal Amount
  • Investors
  • 16

HotSpot Therapeutics General Information

Description

Developer of a therapeutic platform designed for allosteric drug discovery. The company's platform helps to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases as well as leverages a database of hotspot structures, thereby harnessing the power of data science in its multidisciplinary approach to drug discovery, enabling patients to get a conventional treatment against various diseases.

Contact Information

Website
www.hotspotthera.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 50 Milk Street
  • 16th floor
  • Boston, MA 02109
  • United States
+1 (617) 000-0000

HotSpot Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

HotSpot Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 16-Nov-2021 $100M 00000 00000 Completed Generating Revenue
3. Early Stage VC (Series B) 21-May-2020 0000 00000 00000 Completed Generating Revenue
2. Early Stage VC (Series A) 17-Jul-2018 $40M $45M 0000 Completed Product Development
1. Seed Round 23-Feb-2017 $5M $5M 0000 Completed Product Development
To view HotSpot Therapeutics’s complete valuation and funding history, request access »

HotSpot Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A 10,000,000 $0.000100 6% $2 $2 1x $2 10.8%
Seed 5,000,000 $0.000100 6% $1 $1 1x $1 5.4%
To view HotSpot Therapeutics’s complete cap table history, request access »

HotSpot Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a therapeutic platform designed for allosteric drug discovery. The company's platform helps to identify hot
Drug Discovery
Boston, MA
47 As of 2021
00000
0000 0000-00-00
00000000000 00000

0000 000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
0000 000000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

0000000

cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culp
0000 000000000
Labège, France
00 As of 0000
000.00
00.00 0000-00-00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HotSpot Therapeutics Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ROME Therapeutics Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
0000000 Venture Capital-Backed Labège, France 00 000.00 0000000000 0 000.00
0000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
000000 00000000000 Venture Capital-Backed New York, NY 0 0000 00000000000 0000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
You’re viewing 5 of 42 competitors. Get the full list »

HotSpot Therapeutics Executive Team (13)

Name Title Board Seat Contact Info
Jonathan Montagu Co-Founder, President, Chief Executive Officer & Board Member
Timothy Reilly Ph.D Chief Development Officer
Geraldine Harriman Ph.D Co-Founder & Chief Scientific Officer
Andrew Morton Vice President Of Finance
Jim Harwood Ph.D Advisor
You’re viewing 5 of 13 executive team members. Get the full list »

HotSpot Therapeutics Board Members (10)

Name Representing Role Since
Ashish Khanna Ph.D Pivotal bioVenture Partners Board Member 000 0000
Bruce Booth Ph.D Atlas Venture Chairman 000 0000
Daniel Omstead Ph.D Tekla Capital Management Board Member 000 0000
Fouad Azzam Ph.D EQT Life Sciences Board Member 000 0000
Graziano Seghezzi Sofinnova Partners Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

HotSpot Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HotSpot Therapeutics Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CaaS Capital Management Hedge Fund Minority 000 0000 000000 0
EQT Life Sciences Venture Capital Minority 000 0000 000000 0
Monashee Investment Management Hedge Fund Minority 000 0000 000000 0
Pavilion Capital PE/Buyout Minority 000 0000 000000 0
Pivotal bioVenture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

HotSpot Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 23-Aug-2019 0000000000 Biotechnology 000000000
To view HotSpot Therapeutics’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

HotSpot Therapeutics Subsidiaries (1)

Company Name Industry Location Founded
000000000000 Biotechnology Monmouth Junction, NJ 0000
To view HotSpot Therapeutics’s complete subsidiaries history, request access »